COC have formally stated there is insufficient clinical benefit to recommend approval. BSI have received this recommendation. What is the CMO's track record in medical device approvals? Ultimately the buck stops here. The board and even CEO can all say they followed advise from CMO. The CEO hired the CMO. All that's shiny is not gold.
OSL Price at posting:
5.4¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)